Get started
Author

Madeline M. Hartig

Observed names: Hartig, Madeline M., Madeline Hartig
Observed institution: Rogers Behavioral Health
OpenAlex ID: A5114800849
Diagnostic delays in rare genetic disorders with neuropsychiatric manifestations: A systematic review
2025 · Isaac J. Siegel, Sarah L. Vaithilingam, et al. · European Journal of Medical Genetics · 10
Bridging psychiatry and rare genetic diseases: a scoping review of therapeutic strategies and diagnostic delay paired with healthcare economic burden analysis
2025 · Sheldon R. Garrison, Isaac J. Siegel, et al. · Orphanet Journal of Rare Diseases · 7
PDF
Polypharmacy and pharmacogenomics in high-acuity behavioral health care for autism spectrum disorder: a retrospective study
2025 · Sheldon R. Garrison, Sophie A. Schweinert, et al. · Child and Adolescent Psychiatry and Mental Health · 3
PDF
Pharmacogenomic-guided prescribing and polypharmacy across age groups in obsessive-compulsive disorder: a retrospective study
2026 · Sheldon R. Garrison, Matthew W. Boyer, et al. · BMC Psychiatry · 1
Treating disgust in obsessive-compulsive disorder: Clinician perspectives in a survey study
2025 · Rachel A. Schwartz, Madeline Hartig, et al. · Journal of Obsessive-Compulsive and Related Disorders · 1
3.38 Utilization of Pharmacogenomics for ASD: A Retrospective Study
2025 · Sheldon R. Garrison, Sophie A. Schweinert, et al. · Journal of the American Academy of Child & Adolescent Psychiatry
3.39 Impact of Diagnostic Delay on Treatable Rare Genetic Diseases With Associated Neuropsychiatric Symptoms: A Systematic Review
2025 · Sheldon R. Garrison, Isaac J. Siegel, et al. · Journal of the American Academy of Child & Adolescent Psychiatry
P342: Utilization of pharmacogenomics in a child and adolescent autism spectrum disorder depression and anxiety program: A retrospective study
2025 · Sheldon Garrison, Sophie Schweinert, et al. · Genetics in Medicine Open
PDF
Works count: 22
Citation count: 23
H-index: 3
I10-index: 1
Year
Topic
Type